PSNL Collar Strategy
PSNL (Personalis, Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center.
PSNL (Personalis, Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $567.5M, a beta of 1.97 versus the broader market, a 52-week range of 3.84-11.5, average daily share volume of 1.7M, a public-listing history dating back to 2019, approximately 228 full-time employees. These structural characteristics shape how PSNL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.97 indicates PSNL has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a collar on PSNL?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current PSNL snapshot
As of May 15, 2026, spot at $6.40, ATM IV 109.30%, IV rank 21.15%, expected move 31.34%. The collar on PSNL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this collar structure on PSNL specifically: IV regime affects collar pricing on both sides; compressed PSNL IV at 109.30% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 31.34% (roughly $2.01 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PSNL expiries trade a higher absolute premium for lower per-day decay. Position sizing on PSNL should anchor to the underlying notional of $6.40 per share and to the trader's directional view on PSNL stock.
PSNL collar setup
The PSNL collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PSNL near $6.40, the first option leg uses a $6.72 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PSNL chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PSNL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $6.40 | long |
| Sell 1 | Call | $6.72 | N/A |
| Buy 1 | Put | $6.08 | N/A |
PSNL collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
PSNL collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on PSNL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on PSNL
Collars on PSNL hedge an existing long PSNL stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
PSNL thesis for this collar
The market-implied 1-standard-deviation range for PSNL extends from approximately $4.39 on the downside to $8.41 on the upside. A PSNL collar hedges an existing long PSNL position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current PSNL IV rank near 21.15% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PSNL at 109.30%. As a Healthcare name, PSNL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PSNL-specific events.
PSNL collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PSNL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PSNL alongside the broader basket even when PSNL-specific fundamentals are unchanged. Always rebuild the position from current PSNL chain quotes before placing a trade.
Frequently asked questions
- What is a collar on PSNL?
- A collar on PSNL is the collar strategy applied to PSNL (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With PSNL stock trading near $6.40, the strikes shown on this page are snapped to the nearest listed PSNL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PSNL collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the PSNL collar priced from the end-of-day chain at a 30-day expiry (ATM IV 109.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PSNL collar?
- The breakeven for the PSNL collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PSNL market-implied 1-standard-deviation expected move is approximately 31.34%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on PSNL?
- Collars on PSNL hedge an existing long PSNL stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current PSNL implied volatility affect this collar?
- PSNL ATM IV is at 109.30% with IV rank near 21.15%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.